- Home
- IMAB vs TLS Comparison
IMAB vs TLS Comparison
Compare IMAB & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- TLS
- Stock Information
- Founded
- IMAB 2014
- TLS 1969
- Country
- IMAB United States
- TLS United States
- Employees
- IMAB N/A
- TLS N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- TLS EDP Services
- Sector
- IMAB Health Care
- TLS Technology
- Exchange
- IMAB Nasdaq
- TLS Nasdaq
- Market Cap
- IMAB 384.6M
- TLS 403.5M
- IPO Year
- IMAB 2020
- TLS 2020
- Fundamental
- Price
- IMAB $4.38
- TLS $6.27
- Analyst Decision
- IMAB Strong Buy
- TLS Buy
- Analyst Count
- IMAB 4
- TLS 5
- Target Price
- IMAB $6.75
- TLS $4.88
- AVG Volume (30 Days)
- IMAB 2.1M
- TLS 3.1M
- Earning Date
- IMAB 11-02-2025
- TLS 08-11-2025
- Dividend Yield
- IMAB N/A
- TLS N/A
- EPS Growth
- IMAB N/A
- TLS N/A
- EPS
- IMAB N/A
- TLS N/A
- Revenue
- IMAB N/A
- TLS $116,739,000.00
- Revenue This Year
- IMAB N/A
- TLS $47.80
- Revenue Next Year
- IMAB N/A
- TLS $26.19
- P/E Ratio
- IMAB N/A
- TLS N/A
- Revenue Growth
- IMAB N/A
- TLS N/A
- 52 Week Low
- IMAB $0.60
- TLS $1.83
- 52 Week High
- IMAB $5.90
- TLS $6.90
- Technical
- Relative Strength Index (RSI)
- IMAB 54.65
- TLS 67.58
- Support Level
- IMAB $4.17
- TLS $5.90
- Resistance Level
- IMAB $4.69
- TLS $6.29
- Average True Range (ATR)
- IMAB 0.53
- TLS 0.44
- MACD
- IMAB -0.12
- TLS -0.02
- Stochastic Oscillator
- IMAB 25.44
- TLS 57.14
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.